Meet Rick

As an army doctor, cardiac surgeon, and lead guitarist, Rick served his country and fellow man, understanding the importance of trusting teams. See why he trusted his Heart Valve Team and TAVR by Edwards to fix his heart valve failure.


Polaroid of Joy, a real TAVR patient, standing in a train station

Severe aortic stenosis, also known as heart valve failure, is not only scary, it's dangerous—so it's good to know you have a treatment like TAVR (transcatheter aortic valve replacement). TAVR is a way to fix your failing valve without open heart surgery.

Diet and exercise may help fix conditions like high cholesterol and high blood pressure, but not symptoms of heart valve failure. It only gets worse over time and may become deadly without treatment. You have options. Ask your doctor if TAVR is one of them.



All patients diagnosed with heart valve failure and who are experiencing symptoms should ask for a TAVR evaluation. TAVR may also be appropriate for symptomatic patients with bicuspid aortic valves, and for those at high risk for surgery and who need another valve procedure (valve-in-valve).6,7


TAVR doesn't involve opening the chest, meaning it's a minimally invasive way to replace a failing aortic heart valve.*8


As soon as you’re diagnosed with heart valve failure, it’s time to get referred.2,9


Ask your doctor to refer you to a TAVR hospital, where you will be evaluated by a Heart Valve Team to see if TAVR is right for you.


Your life belongs to you, not heart valve failure. Take it back with TAVR.8

Dr. Dearman, a TAVR patient and cardiac surgeon

What happens when a cardiac surgeon is the one who needs a TAVR?

Watch video
Most TAVR patients:10-12
One hour icon

Are finished with
the procedure in
about 1 hour

Icon of person walking

Are up and
walking within

Icon of a person inside of a house

Go home the
next day

Icon of the number 30 on a calendar

Recover quickly and
start feeling like
themselves in
about 30 days

The major risks of TAVR include death, stroke, serious damage to the arteries, or serious bleeding.

SAPIEN 3 TAVR is proven superior to surgery in low-risk patients at 1 year—and proven equally effective at 5 years.*12,13


The PARTNER 3 Trial, SAPIEN 3 TAVR proven superior to surgery on the primary endpoint of all-cause death, all stroke, and re-hospitalization (valve-related or procedure-related and including heart failure) at one year, and multiple pre-specified secondary endpoints in low risk patients.

PARTNER 3 Trial 5-Year Results in low-risk patients – Low rates of cardiovascular mortality through five years (5.5% SAPIEN 3 TAVR to 5.1% SAVR). Low rates of all-cause mortality through five years (10.1% SAPIEN 3 TAVR vs. 8.2% with SAVR). Low rates of disabling stroke through five years (2.9% SAPIEN 3 TAVR to 2.7% SAVR). Low rates of stroke through five years (5.8% SAPIEN 3 TAVR vs. 6.4% SAVR). Lower rates of rehospitalization with SAPIEN 3 TAVR through five years (13.7% vs. 17.4%).

Polaroid of James, a real TAVR patient, looking at a map with a woman in the background

Have heart valve failure?

It’s critical to get referred to a Heart Valve Team right away.

Find one here

Not all TAVR valves are the same

See why receiving a TAVR valve by Edwards matters.

Get TAVR info
Icon of a heart valve

Get your TAVR Info Kit

Each kit is packed with valuable information and resources to help you better understand TAVR.

Get your kit
Icon of a checklist
References: 1.National Heart, Lung, and Blood Institute. Heart valve diseases treatment. Accessed March 7, 2024. 2.American Heart Association. Managing aortic stenosis symptoms. Accessed March 7, 2024. 3.American Heart Association. Life's Essential 8™: how to manage blood pressure fact sheet. Accessed March 7, 2024. 4.American Heart Association. Prevention and treatment of high cholesterol (hyperlipidemia). Accessed March 7, 2024. 5.Malaisrie SC, McDonald E, Kruse J, et al. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014;98(5):1564-1571. 6.Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol. 2020;75(16):1882-1893. 7.Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72-e227. 8.American Heart Association. Newer heart valve surgery options. Accessed March 7, 2024. 9.Otto CM. Timing of aortic valve surgery. Heart. 2000;84(2):211-218. 10.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients [supplementary appendix]. N Engl J Med. 2019;380(18):1695-1705. 11.Cleveland Clinic. Transcatheter aortic valve replacement. Accessed March 7, 2024. 12.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705. 13.Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023;389(21):1949-1960.

Patients and/or clinicians quoted on this website have received compensation from Edwards Lifesciences.